Neovascularization, Choroidal
3 clinical trials · Condition
◉ Watch Neovascularization, Choroidal
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (NCT03038880) | Hoffmann-La Roche | 2017-01-27 |
Track Neovascularization, Choroidal automatically
Every clearance here is in the API, with alerts when new ones post.